Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

5.2K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
5.2K
Erythropoiesis01:14

Erythropoiesis

5.5K
Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
5.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adjunctive transcranial DC stimulation in the management of refractory drug-resistant focal epilepsy in POLG mitochondrial disease: A case series.

Seizure·2026
Same author

Implementation of pathogen reduced cryoprecipitate for surgical services: A retrospective review of blood product utilization and fibrinogen repletion.

Transfusion·2025
Same author

Differences in the product characteristics and clinical use of granulocytes for transfusion: The BEST Collaborative study.

Transfusion·2025
Same author

Residual red blood cells in liquid plasma products: A quality assessment.

American journal of clinical pathology·2025
Same author

Granulocyte Transfusion in Pediatric and Adult Neutropenic Patients: A 16-Year Retrospective Review.

Cureus·2025
Same author

Improving RBC inventory by optimizing preoperative ordering and eliminating crossmatch and hold.

Transfusion·2024
Same journal

Spray dried plasma manufactured from apheresis and whole blood derived plasma.

Transfusion·2026
Same journal

Identification of a novel ABO*A1.01 allele with c.562C>T (p.Arg188Cys) mutation associated with A<sub>el</sub> phenotype in a Chinese individual.

Transfusion·2026
Same journal

AABB survey on directed blood donation practices.

Transfusion·2026
Same journal

Cost analysis considerations for red blood cell matching to mitigate alloimmunization in patients with sickle cell disease.

Transfusion·2026
Same journal

A novel translation initiation codon single nucleotide variant of the SLC14A1 (c.2T>G) from a Chinese blood donor with Jk(a-b-) phenotype.

Transfusion·2026
Same journal

Size (and frequency) matter: Evaluating the best management practices for blood products with spotty demand.

Transfusion·2026
See all related articles

Related Experiment Video

Updated: Dec 28, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.9K

Optimizing O-negative RBC utilization using a data-driven approach.

Mrigender S Virk1,2, David Lancaster3, Thinh Quach2

  • 1Department of Pathology, Stanford University School of Medicine, Stanford, California.

Transfusion
|February 21, 2020
PubMed
Summary
This summary is machine-generated.

Optimizing O-negative red blood cell (ON-RBC) inventory reduced inappropriate transfusions by 13%, saving approximately 185 units in six months. This blood bank strategy improves utilization and resource management.

More Related Videos

Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes
08:53

Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes

Published on: January 10, 2025

836
Prediction of Red Blood Cell Antibody Significance Using the Monocyte-Macrophage Assay
11:27

Prediction of Red Blood Cell Antibody Significance Using the Monocyte-Macrophage Assay

Published on: February 7, 2025

898

Related Experiment Videos

Last Updated: Dec 28, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.9K
Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes
08:53

Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes

Published on: January 10, 2025

836
Prediction of Red Blood Cell Antibody Significance Using the Monocyte-Macrophage Assay
11:27

Prediction of Red Blood Cell Antibody Significance Using the Monocyte-Macrophage Assay

Published on: February 7, 2025

898

Area of Science:

  • Transfusion Medicine
  • Blood Banking Operations
  • Healthcare Resource Management

Background:

  • O-negative red blood cells (ON-RBC) are a critical resource facing concerns over inappropriate use.
  • Hospital blood banks require internal strategies beyond donor recruitment and universal typing.
  • Optimizing inventory and policies is key for appropriate ON-RBC utilization.

Purpose of the Study:

  • To reduce inappropriate transfusions of O-negative red blood cells (ON-RBC).
  • To optimize blood bank inventory management for ON-RBCs.
  • To assess the impact of inventory reduction on transfusion timing and appropriateness.

Main Methods:

  • Analyzed one year of transfusion data for out-of-group/inappropriate ON-RBC rates.
  • Assessed the relationship between transfusion rate and product age (days from expiration).
  • Examined stock inventory levels and their contribution to inappropriate ON-RBC usage.

Main Results:

  • Decreased ON-RBC inventory reduced inappropriate transfusions from 67% to 54% (p=0.0035).
  • Transfusions occurred earlier in shelf-life (9.27 vs. 11.15 days DFE, p=0.0012).
  • Approximately 185 units of ON-RBC were saved over six months.

Conclusions:

  • A data-driven inventory optimization strategy effectively reduces inappropriate ON-RBC transfusions.
  • This approach improves resource utilization and conserves precious blood products.
  • The methodology is applicable to other institutions and can set a benchmark for blood banking.